Navigation Links
Reportlinker Adds Generic and innovative drug market in CE countries 2011 - Comparative analysis, reimbursement policies and development forecasts for 2011-2013
Date:2/15/2011

NEW YORK, Feb. 15, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Generic and innovative drug market in CE countries 2011 - Comparative analysis, reimbursement policies and development forecasts for 2011-2013

http://www.reportlinker.com/p0395681/Generic-and-innovative-drug-market-in-CE-countries-2011---Comparative-analysis-reimbursement-policies-and-development-forecasts-for-2011-2013 .html

Generic and innovative drug market in CE countries 2011 is a unique new report that provides a detailed illustration of the current market conditions in Central Europe, both as one cohesive region and in the individual marketplaces of:

Poland, Romania, Slovakia, the Czech Republic, Hungary and Bulgaria.

In addition to the latest analysis of key effects of recent economic difficulties in these markets, this timely document provides comparative analysis, news on reimbursement policies and the development forecasts for 2011-2013 needed for success in this quickly changing industry.

The expert analysts at PMR Publications have closely examined the issues that affect market conditions and require skillful navigation within today's CE generic and innovative drug market:

̶
prices

̶
reimbursement policies

̶
insurers, exclusivity of data regulations

̶
formula patent time periods

̶
expiration dates

̶
counterfeit medicines.

They have carefully compiled their research, analysis and projections to create a single concise and cost-effective document that saves readers time and money by offering the widest scope of necessary coverage without sacrificing any of the required detail.

The report presents a sharply-focused view of the future by predicting changes in market size and share for the coming two years, as well as in-depth treatment of current and future reimbursement lists and processes and their impact on the market. It examines VAT rates, and outlines expected changes in data exclusivity periods allotted to innovative medicine companies.

Readers will gain an insightful understanding of the behaviour and reasoning of market participants through detailed description of:

̶
the preferences of the consumer, medical patient and prescribing physician concerning generics and innovative drugs

̶
company profiles that spotlight the activities and achievements of the largest developers, manufacturers and distributors of the many products that are classified in this specific portion of the region's pharmaceutical market.

To order this report:: Generic and innovative drug market in CE countries 2011 - Comparative analysis, reimbursement policies and development forecasts for 2011-2013 More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Contact:Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... 2017 NuvoAir (formerly called Pond Healthcare ... a partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry ... the leading mobile spirometry platform and Novartis, commitment to address ... ... ...
(Date:9/6/2017)... 2017  Robert G. Szewc, M.D., is recognized by ... recognition of his contributions to the Medical field.      ... at the practice of Kidney and Hypertension Specialists, which ... hypertension solutions. He has worked in this position since ... as well as expertise in kidneys, hypertension, chronic disease ...
(Date:9/6/2017)... 6, 2017 NeuroRx, a clinical stage biopharma company ... Behavior (ASIB), has been granted Fast Track status by the ... NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). The ... of this sequential therapy targeting patients who are admitted to ... ...
Breaking Medicine Technology:
(Date:9/25/2017)... ... 25, 2017 , ... FDAnews Expert Insight Series:, Device Regulation ... – 3:00 p.m. ET, http://www.fdanews.com/deviceregulation      , FDA Commissioner Scott ... short months:, ,     The first device recall over cybersecurity (a ...
(Date:9/25/2017)... ... September 25, 2017 , ... The Byron Eaton Agency, ... the central Alabama region, is organizing a local charity drive to send money and ... 11 trillion gallons of water have fallen on Houston as a result of Hurricane ...
(Date:9/25/2017)... , ... September 25, 2017 , ... ... the launch of its new website. No need to be concerned about ... answer. Go to welldonedesigns.com where all orders are printed and shipped within 5-10 ...
(Date:9/25/2017)... , ... September 25, 2017 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... development and validation of bioassays at two upcoming conferences. , At the BEBPA ...
(Date:9/25/2017)... ... 25, 2017 , ... NCPDP Foundation , a 501(c)(3) ... awarded a $40,000 grant to Johns Hopkins Medicine to address patient safety risk ... to electronically cancel a prescription already submitted to a pharmacy. Studies indicate that ...
Breaking Medicine News(10 mins):